Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center-Reference-Cited by-同舟云学术

Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center

Published:2019-03-20 Issue:1 Volume:18 Page:
ISSN:1476-0711
Container-title:Annals of Clinical Microbiology and Antimicrobials
language:en
Short-container-title:Ann Clin Microbiol Antimicrob

Author:

Van Matre Edward T.^ORCID,Evans Shelby L.,Mueller Scott W.,MacLaren Robert,Fish Douglas N.,Kiser Tyree H.^ORCID

Funder

Astellas Pharma US

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12941-019-0311-3.pdf

Reference19 articles.

1. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50(8):1091–100.

2. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, et al. Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET). Clin Infect Dis. 2010;50(8):1101–11.

3. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.

4. Ibrahim AS, Edwards JE Jr, Bryant R, Spellberg B. Economic burden of mucormycosis in the United States: can a vaccine be cost-effective? Med Mycol. 2009;47(6):592–600.

5. Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases Society of America. Clin infect Dis. 2016;63(4):e1–60.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic and computational-aided integrative drug repositioning strategy for EGFR and ROS1 mutated NSCLC;International Immunopharmacology;2024-09

2. Pipeline of Novel Antifungals for Invasive Fungal Disease in Transplant Recipients: A Pediatric Perspective;Journal of the Pediatric Infectious Diseases Society;2024-02-01

3. A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections;Mycoses;2023-06-10

4. Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies;Journal of Fungi;2023-05-19

5. Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now;Expert Review of Anti-infective Therapy;2023-05-01